Journal of Pharmaceutical and Biomedical Analysis · 2011 · 30 citations · 21 references
PharmacyBiotechnologyImmunologyAntibody EngineeringAutoimmunityRheumatologyAntibody CharacterizationAntibody FunctionAutoimmune Rheumatic DiseasesFc EngineeringImmunogenicity Of Therapeutic AntibodiesRheumatoid ArthritisAntibody Fc Fusion ProteinsAntibody Therapeutic EfficacyFc Region ImmunogenicityFc-mediated Effector Function EnhancementImmunogenicity EndpointsRecombinant Antibody EngineeringTherapeutic Antibody Fc Design
21
Robert L. Shields, Angela K. Namenuk, Kyu Hong et al. · Journal of Biological Chemistry · 2001 · 1.2K citations · Full text
Anthony R. Mire‐Sluis, Yu Chen Barrett, Viswanath Devanarayan et al. · Journal of Immunological Methods · 2004 · 621 citations
An Engineered Human IgG1 Antibody with Longer Serum Half-Life
Paul R. Hinton, Joanna M. Xiong, Mary G. Johlfs et al. · The Journal of Immunology · 2006 · 281 citations · Full text